No penalties for stunning gray price hikes on cancer, anesthesia drugs

PBS Newshour health correspondent Betty Ann Bowser dove into the drug shortages pool recently, gaining access to Captain Valerie Jensen, assistant director for the FDA office that tracks shortages. The pair covered the usual ground of manufacturing and supply chain GMP issues, profitability, raw material shortages and so on. But then Jensen addressed the far-less-discussed gray market. "Suppliers hoard drugs in anticipation of a shortage, and, when it happens, they jack up the price...The gray marketers have been asking hospitals to pay an average of 650% higher than the normal price for some oncology drugs and anesthesia products. And in most states, there is nothing illegal about this practice." Transcript and 9-minute video

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.